Naomi Rahimi‐Levene
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 16
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Hematology top 5%
- Blood groups and transfusion 6
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 12
-
- Immunodeficiency and Autoimmune Disorders 7
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 5
-
- Blood transfusion and management 7
- Co-authors
- Maya Koren‐MichowitzOdit GutweinLev ShvidelOsnat BaireyAaron PolliackArie ApelAbraham KornbergTamar Tadmor
- Partner nations
- IsraelUnited StatesIndia
In The Last Decade
Naomi Rahimi‐Levene
50 papers receiving 615 citations
Peers
Comparison fields: 5 of 83
- Genetics 272
- Hematology 164
- Pathology and Forensic Medicine 166
- Immunology 161
- Infectious Diseases 140
Countries citing papers authored by Naomi Rahimi‐Levene
This map shows the geographic impact of Naomi Rahimi‐Levene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Rahimi‐Levene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Rahimi‐Levene more than expected).
Fields of papers citing papers by Naomi Rahimi‐Levene
This network shows the impact of papers produced by Naomi Rahimi‐Levene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Rahimi‐Levene. The network helps show where Naomi Rahimi‐Levene may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naomi Rahimi‐Levene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 106 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 15 | |
| 11 | 2019 | 7 | |
| 12 | 2018 | 12 | |
| 13 | 2018 | 5 | |
| 14 | 2017 | 3 | |
| 15 | 2012 | 13 | |
| 16 | 2012 | 25 | |
| 17 | 2003 | 21 | |
| 18 | 2000 | 2 | |
| 19 | 1997 | 23 | |
| 20 | 1997 | 9 |
About Naomi Rahimi‐Levene
Naomi Rahimi‐Levene is a scholar working on Genetics, Hematology and Biochemistry, having authored 51 papers that have together received 630 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (12 papers), Blood transfusion and management (7 papers), COVID-19 Clinical Research Studies (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Blood groups and transfusion (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Genetics (272 citations), Hematology (164 citations) and Pathology and Forensic Medicine (166 citations). Naomi Rahimi‐Levene has collaborated with scholars based in Israel, United States and India. Frequent co-authors include Maya Koren‐Michowitz, Odit Gutwein, Lev Shvidel, Osnat Bairey, Aaron Polliack, Arie Apel, Abraham Kornberg, Tamar Tadmor, Yair Herishanu and Rosa Ruchlemer. Their work appears in journals such as Blood, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.